29 results
DEF 14A
TARS
Tarsus Pharmaceuticals Inc
30 Apr 21
Definitive proxy
4:03pm
MATERIAL AND VOTING
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECTION 16 … Canyon Road, Suite 160, Irvine, CA 92618, Attn: Corporate Secretary.
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
DIRECTORSAND EXECUTIVE
8-K
TARS
Tarsus Pharmaceuticals Inc
7 Dec 22
Departure of Directors or Certain Officers
8:49am
and Corporate Governance Committee, the Board authorized and approved the appointment of Bobak Azamian, the Company’s Chief Executive Officer
8-K
6hrbtdl
20 Nov 20
Tarsus Pharmaceuticals, Inc. Appoints Wendy Yarno to Board of Directors
4:25pm
8-K
6mmm5l5ig1itw
4 Jan 22
Tarsus Appoints Elizabeth Yeu, M.D., a Nationally Recognized Ophthalmologist and Eye Care Leader, to its Board of Directors
4:15pm
8-K
f09s7 ji3fk7a
12 Aug 21
Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare Industry Leader Rosemary A. Crane to Board of Directors
4:01pm
8-K
tlyyyvdyluj5efun
12 Oct 22
Departure of Directors or Certain Officers
4:21pm
8-K
EX-99.1
klisaa6j sff
4 Jan 22
Tarsus Appoints Elizabeth Yeu, M.D., a Nationally Recognized Ophthalmologist and Eye Care Leader, to its Board of Directors
4:15pm
CORRESP
ib4b0l ljjumerr3dns
13 Apr 23
Correspondence with SEC
12:00am
S-1/A
8rymud9byqn
9 Oct 20
IPO registration (amended)
5:16pm
424B4
7rs t2xgt
16 Oct 20
Prospectus supplement with pricing info
4:40pm
S-1
e6hsgdu
25 Sep 20
IPO registration
5:25pm
DRS
gs6xus9igk03qf
7 Aug 20
Draft registration statement
12:00am
DRS/A
vpeesz
14 Sep 20
Draft registration statement (amended)
12:00am
8-K
EX-3.2
kod2 qrmc
20 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:36pm
S-1/A
EX-3.4
xzc i34p5
9 Oct 20
IPO registration (amended)
5:16pm
ARS
y1dtobe
26 Apr 24
Annual report to shareholders
4:27pm